Trudeau commits $214m for COVID-19 vaccine research

Prime Minister Trudeau

Canadian Prime Minister Trudeau

Canadian Prime Minister Trudeau: announces plans for homegrown COVID-19 vaccine

Prime Minister Justin Trudeau said Friday the government is spending $214 million to support “made in Canada” COVID-19 vaccine research.

According to him, $173 million would go to Quebec-based Medicago, while Vancouver’s Precision NanoSystems would receive $18.2 million for development and testing.

“This is about securing potential vaccines for Canadians while supporting good jobs in research,” he told reporters at a press conference in Ottawa.

The deal with Medicago includes up to 76 million doses of its vaccine candidate, as well as funds to set up a production facility in Quebec City.

A further $23 million will go toward the National Research Council of Canada Industrial Research Assistance Program.

His announcement came after Canada posted a record increase in new COVID-19 cases on Thursday, with nearly 2,800 people newly diagnosed with the illness.

Related News

“We have to get these numbers down,” Trudeau said. “This is serious and everybody must do their part.”

Till date, the Canadian government has spent more than $1 billion to secure doses of a vaccine against the coronavirus.

Deals have been struck with half a dozen pharmaceutical giants, and Canada is also part of an international vaccine alliance through COVAX.

“Canada has an excellent portfolio of vaccine potential, but we also know, nobody’s got that vaccine yet,” Trudeau said.

Trudeau said the “reasonable expectation” is that vaccines could arrive sometime in the new year, but there will be smaller amounts available and the shots would be going to priority groups such as frontline workers and the most vulnerable populations first.

Reported by globalnews.ca

Load more